Login

Cipla Ltd.

₹1462.65

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Cipla Ltd.

₹1462.65

₹1462.65

-33.05 (-2.21%) - 4 Apr 2025 09:37 AM

About Company

Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.

Market Cap. ₹120,795 Cr.
52 Week - High/Low ₹1,702/1,317
P/E Ratio 25.64
P/B Ratio 4.32
Enterprise Value ₹120,679 Cr.
ROE % 14.14
RSI Value 55.43
EMA 50 1470.5
EMA 200 1476.55
Net Profit 4,077 Cr.
Net Profit 3year growth 65.19 Cr.
Net Profit 3 year (back) 2,468 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 38.74 %
Current Ratio 5.19 %
100 Day SMA 1,474 Rs.
200 Day SMA 1,521 Rs.
21 Day SMA 1,469 Rs.
50 Day SMA 1,458 Rs.
Book Value 346 Rs.
EV/EBITDA Ratio 19
QoQ EPS Growth 22 %
QoQ Operating Profit Growth 16 %
QoQ Sales Growth 4 %
Sales Latest Quarter 4,135 Cr.
YoY Sales Growth 13 %
Market Cap. ₹120,795 Cr.
52 Week - High/Low ₹1,702/1,317
P/E Ratio 24.21
P/B Ratio 4.52
Enterprise Value ₹120,002 Cr.
ROE % 16.63
RSI Value 55.43
EMA 50 1470.5
EMA 200 1476.55
Net Profit 4,122 Cr.
Net Profit 3year growth 6.56 Cr.
Net Profit 3 year (back) 2,405 Cr.
Debt to Equity 0.01 %
EPS Growth TTM 34.5 %
Current Ratio 3.7 %
100 Day SMA 1,474 Rs.
200 Day SMA 1,521 Rs.
21 Day SMA 1,469 Rs.
50 Day SMA 1,458 Rs.
Book Value 331 Rs.
EV/EBITDA Ratio 16
QoQ EPS Growth 21 %
QoQ Operating Profit Growth 5 %
QoQ Sales Growth 0 %
Sales Latest Quarter 6,962 Cr.
YoY Sales Growth 7 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.